Article Details
Retrieved on: 2024-02-20 20:49:59
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the performance and potential of biotech in the IPO market, highlighting Renaissance Capital's analysis and the steady yet volatile nature of the S&P 500 and exchange-traded funds (ETFs).
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here